ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
159 hedge funds and large institutions have $1.17B invested in iTeos Therapeutics in 2022 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $1.55B → $1.17B (-$387M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
83% less call options, than puts
Call options by funds: $343K | Put options by funds: $2.07M
Holders
159
Holding in Top 10
5
Calls
$343K
Puts
$2.07M
Top Buyers
| 1 | +$55.3M | |
| 2 | +$45.1M | |
| 3 | +$30.5M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$21.6M |
| 5 |
Morgan Stanley
New York
|
+$20.5M |
Top Sellers
| 1 | -$60M | |
| 2 | -$39.6M | |
| 3 | -$37.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15.4M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$11.3M |